Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Journal of Geriatric Oncology
|
March 16, 2017
Follow-up of elderly patients with urogenital cancers: Evaluation of geriatric care needs and related actions
Silvio Monfardini, Sara Morlino, Riccardo Valdagni, et al.
Clinical Lung Cancer
|
May 10, 2011
Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutations
Gabriella Farina, Flavia Longo, Olga Martelli, et al.
Scientific Reports
|
November 18, 2015
Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)
Monica Ganzinelli, Eliana Rulli, Elisa Caiola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study
Paolo Maione, Francesco Perrone, Ciro Gallo, et al.
British Journal of Cancer
|
September 11, 2003
Supportive care in patients with advanced non-small-cell lung cancer
M Di Maio, F Perrone, C Gallo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Journal of Geriatric Oncology
|
March 16, 2017
Follow-up of elderly patients with urogenital cancers: Evaluation of geriatric care needs and related actions
Silvio Monfardini, Sara Morlino, Riccardo Valdagni, et al.
Clinical Lung Cancer
|
May 10, 2011
Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutations
Gabriella Farina, Flavia Longo, Olga Martelli, et al.
Scientific Reports
|
November 18, 2015
Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)
Monica Ganzinelli, Eliana Rulli, Elisa Caiola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study
Paolo Maione, Francesco Perrone, Ciro Gallo, et al.
British Journal of Cancer
|
September 11, 2003
Supportive care in patients with advanced non-small-cell lung cancer
M Di Maio, F Perrone, C Gallo, et al.
Page
of 2